These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 26636106)
21. Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up. Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT JACC Heart Fail; 2017 Mar; 5(3):204-212. PubMed ID: 28254126 [TBL] [Abstract][Full Text] [Related]
22. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Zareba W; Klein H; Cygankiewicz I; Hall WJ; McNitt S; Brown M; Cannom D; Daubert JP; Eldar M; Gold MR; Goldberger JJ; Goldenberg I; Lichstein E; Pitschner H; Rashtian M; Solomon S; Viskin S; Wang P; Moss AJ; Circulation; 2011 Mar; 123(10):1061-72. PubMed ID: 21357819 [TBL] [Abstract][Full Text] [Related]
23. Clinical Implications of Complete Left-Sided Reverse Remodeling With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy. Mathias A; Moss AJ; McNitt S; Zareba W; Goldenberg I; Solomon SD; Kutyifa V J Am Coll Cardiol; 2016 Sep; 68(12):1268-76. PubMed ID: 27634117 [TBL] [Abstract][Full Text] [Related]
24. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490 [TBL] [Abstract][Full Text] [Related]
25. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. Vanderheyden M; Mullens W; Delrue L; Goethals M; de Bruyne B; Wijns W; Geelen P; Verstreken S; Wellens F; Bartunek J J Am Coll Cardiol; 2008 Jan; 51(2):129-36. PubMed ID: 18191736 [TBL] [Abstract][Full Text] [Related]
26. Survival with cardiac-resynchronization therapy in mild heart failure. Goldenberg I; Kutyifa V; Klein HU; Cannom DS; Brown MW; Dan A; Daubert JP; Estes NA; Foster E; Greenberg H; Kautzner J; Klempfner R; Kuniss M; Merkely B; Pfeffer MA; Quesada A; Viskin S; McNitt S; Polonsky B; Ghanem A; Solomon SD; Wilber D; Zareba W; Moss AJ N Engl J Med; 2014 May; 370(18):1694-701. PubMed ID: 24678999 [TBL] [Abstract][Full Text] [Related]
27. Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis. Adabag S; Roukoz H; Anand IS; Moss AJ J Am Coll Cardiol; 2011 Aug; 58(9):935-41. PubMed ID: 21851882 [TBL] [Abstract][Full Text] [Related]
28. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy. Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593 [TBL] [Abstract][Full Text] [Related]
29. Left atrial volume and the benefit of cardiac resynchronization therapy in the MADIT-CRT trial. Kuperstein R; Goldenberg I; Moss AJ; Solomon S; Bourgoun M; Shah A; McNitt S; Zareba W; Klempfner R Circ Heart Fail; 2014 Jan; 7(1):154-60. PubMed ID: 24347664 [TBL] [Abstract][Full Text] [Related]
30. Hospital-based and telemonitoring guided home-based training programs: effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. A randomized, prospective observation. Smolis-Bąk E; Dąbrowski R; Piotrowicz E; Chwyczko T; Dobraszkiewicz-Wasilewska B; Kowalik I; Kazimierska B; Jędrzejczyk B; Smolis R; Gepner K; Maciąg A; Sterliński M; Szwed H Int J Cardiol; 2015 Nov; 199():442-7. PubMed ID: 26276068 [TBL] [Abstract][Full Text] [Related]
31. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure. Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR; Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828 [TBL] [Abstract][Full Text] [Related]
32. Effect of Cardiac Resynchronization Therapy on Myocardial Fibrosis and Relevant Cytokines in a Canine Model With Experimental Heart Failure. Wang J; Gong X; Chen H; Qin S; Zhou N; Su Y; Ge J J Cardiovasc Electrophysiol; 2017 Apr; 28(4):438-445. PubMed ID: 28127817 [TBL] [Abstract][Full Text] [Related]
33. Effect of Cardiac Resynchronization Therapy in Patients With Insulin-Treated Diabetes Mellitus. Szepietowska B; Kutyifa V; Ruwald MH; Solomon SD; Ruwald AC; McNitt S; Polonsky B; Thomas S; Moss AJ; Zareba W Am J Cardiol; 2015 Aug; 116(3):393-9. PubMed ID: 26048851 [TBL] [Abstract][Full Text] [Related]
34. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling. Ruwald AC; Kutyifa V; Ruwald MH; Solomon S; Daubert JP; Jons C; Brenyo A; McNitt S; Do D; Tanabe K; Al-Ahmad A; Wang P; Moss AJ; Zareba W Eur Heart J; 2015 Feb; 36(7):440-8. PubMed ID: 25112662 [TBL] [Abstract][Full Text] [Related]
36. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058 [TBL] [Abstract][Full Text] [Related]
37. [The assessment of factors influencing occurrence of adequate interventions of cardiac resynchronization therapy with cardioverter-defibrillator implanted in primary prevention of sudden cardiac death in dilative cardiomyopathy and percentage of biventricular pacing]. Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J; Matusik P Przegl Lek; 2017; 74(4):157-62. PubMed ID: 29696953 [TBL] [Abstract][Full Text] [Related]
38. Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization therapy in advanced heart failure. Imamura T; Kinugawa K; Nitta D; Komuro I Circ J; 2015; 79(11):2414-21. PubMed ID: 26376671 [TBL] [Abstract][Full Text] [Related]
39. The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device-A MADIT-CRT substudy. Aktas MK; Zareba W; Huang DT; McNitt S; Polonsky S; Chen L; Stockburger M; Merkely B; Moss AJ; Kutyifa V J Card Fail; 2014 Mar; 20(3):183-9. PubMed ID: 24361804 [TBL] [Abstract][Full Text] [Related]
40. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy. Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]